{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:33:28Z","timestamp":1793658808596,"version":"4.5.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003542","name":"Ministerium f\u00fcr Wissenschaft, Forschung und Kunst Baden-W\u00fcrttemberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the revised diagnostic classification systems ICD-11 and DSM-5, secondary, organic forms of obsessive-compulsive disorder (OCD) are implemented as specific nosological entities. Therefore, the aim of this study was to clarify whether a comprehensive screening approach, such as the Freiburg-Diagnostic-Protocol for patients with OCD (FDP-OCD), is beneficial for detecting organic OCD forms. The FDP-OCD includes advanced laboratory tests, an expanded magnetic resonance imaging (MRI) protocol, and electroencephalography (EEG) investigations as well as automated MRI and EEG analyses. Cerebrospinal fluid (CSF), [<jats:sup>18<\/jats:sup>F]fluorodeoxyglucose positron emission tomography, and genetic analysis were added for patients with suspected organic OCD. The diagnostic findings of the first 61 consecutive OCD inpatients (32 female and 29 male; mean age: 32.7\u2009\u00b1\u200912.05\u2009years) analyzed using our protocol were investigated. A probable organic cause was assumed in five patients (8%), which included three patients with autoimmune OCD (one patient with neurolupus and two with specific novel neuronal antibodies in CSF) and two patients with newly diagnosed genetic syndromes (both with matching MRI alterations). In another five patients (8%), possible organic OCD was detected (three autoimmune cases and two genetic cases). Immunological serum abnormalities were identified in the entire patient group, particularly with high rates of decreased \u201cneurovitamin\u201d levels (suboptimal vitamin D in 75% and folic acid in 21%) and increased streptococcal (in 46%) and antinuclear antibodies (ANAs; in 36%). In summary, the FDP-OCD screening led to the detection of probable or possible organic OCD forms in 16% of the patients with mostly autoimmune forms of OCD. The frequent presence of systemic autoantibodies such as ANAs further support the possible influence of autoimmune processes in subgroups of patients with OCD. Further research is needed to identify the prevalence of organic OCD forms and its treatment options.<\/jats:p>","DOI":"10.1038\/s41398-023-02368-8","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T15:04:35Z","timestamp":1678201475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Deep clinical phenotyping of patients with obsessive-compulsive disorder: an approach towards detection of organic causes and first results"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0263-4360","authenticated-orcid":false,"given":"Kimon","family":"Runge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Reisert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9436-1258","authenticated-orcid":false,"given":"Bernd","family":"Feige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9863-317X","authenticated-orcid":false,"given":"Kathrin","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Urbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7729-2759","authenticated-orcid":false,"given":"Nils","family":"Venhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6840-965X","authenticated-orcid":false,"given":"Andreas","family":"Tzschach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam A.","family":"Schiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0911-5758","authenticated-orcid":false,"given":"Luciana","family":"Hannibal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8283-7976","authenticated-orcid":false,"given":"Harald","family":"Pr\u00fcss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2550-9132","authenticated-orcid":false,"given":"Katharina","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2274-5447","authenticated-orcid":false,"given":"Ludger","family":"Tebartz van Elst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7322-1195","authenticated-orcid":false,"given":"Dominique","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"key":"2368_CR1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00127-010-0337-5","volume":"47","author":"Y Adam","year":"2012","unstructured":"Adam Y, Meinlschmidt G, Gloster AT, Lieb R. Obsessive-compulsive disorder in the community: 12-month prevalence, comorbidity and impairment. Soc Psychiatry Psychiatr Epidemiol. 2012;47:339\u201349.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2368_CR2","first-page":"156","volume":"254","author":"J Angst","year":"2004","unstructured":"Angst J, Gamma A, Endrass J, Goodwin R, Ajdacic V, Eich D, et al. Obsessive-compulsive severity spectrum in the community: prevalence, comorbidity, and course. Eur Arch Psychiatry Clin Neurosci. 2004;254:156\u201364.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2368_CR3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00115-013-3961-y","volume":"85","author":"F Jacobi","year":"2014","unstructured":"Jacobi F, H\u00f6fler M, Strehle J, Mack S, Gerschler A, Scholl L, et al. Psychische St\u00f6rungen inder Allgemeinbev\u00f6lkerung: Studie zur Gesundheit Erwachsener in Deutschland und ihrZusatzmodul Psychische Gesundheit (DEGS1-MH). Nervenarzt. 2014;85:77\u201387.","journal-title":"Nervenarzt"},{"key":"2368_CR4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40263-013-0056-z","volume":"27","author":"M Subramaniam","year":"2013","unstructured":"Subramaniam M, Soh P, Vaingankar JA, Picco L, Chong SA. Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment. CNS Drugs. 2013;27:367\u201383.","journal-title":"CNS Drugs"},{"key":"2368_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuron.2019.01.046","volume":"102","author":"TW Robbins","year":"2019","unstructured":"Robbins TW, Vaghi MM, Banca P. Obsessive-compulsive disorder: puzzles and prospects. Neuron. 2019;102:27\u201347.","journal-title":"Neuron"},{"key":"2368_CR6","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-019-1062-8","volume":"21","author":"M Gerentes","year":"2019","unstructured":"Gerentes M, Pelissolo A, Rajagopal K, Tamouza R, Hamdani N. Obsessive-compulsive disorder: autoimmunity and neuroinflammation. Curr Psychiatry Rep. 2019;21:78.","journal-title":"Curr Psychiatry Rep"},{"key":"2368_CR7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/da.20792","volume":"28","author":"E Real","year":"2011","unstructured":"Real E, Labad J, Alonso P, Segal\u00e0s C, Jim\u00e9nez-Murcia S, Bueno B, et al. Stressful life events at onset of obsessive-compulsive disorder are associated with a distinct clinical pattern. Depress Anxiety. 2011;28:367\u201376.","journal-title":"Depress Anxiety"},{"key":"2368_CR8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrn3746","volume":"15","author":"DL Pauls","year":"2014","unstructured":"Pauls DL, Abramovitch A, Rauch SL, Geller DA. Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci. 2014;15:410\u201324.","journal-title":"Nat Rev Neurosci"},{"key":"2368_CR9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-019-0102-3","volume":"5","author":"DJ Stein","year":"2019","unstructured":"Stein DJ, Costa DLC, Lochner C, Miguel EC, Reddy YCJ, Shavitt RG, et al. Obsessive-compulsive disorder. Nat Rev Dis Prim. 2019;5:52.","journal-title":"Nat Rev Dis Prim"},{"key":"2368_CR10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/ijnp\/pyaa016","volume":"23","author":"MA Schiele","year":"2020","unstructured":"Schiele MA, Thiel C, Deckert J, Zaudig M, Berberich G, Domschke K. Monoamine oxidase A hypomethylation in obsessive-compulsive disorder: reversibility by successful psychotherapy? Int J Neuropsychopharmacol. 2020;23:319\u201323.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2368_CR11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s00115-022-01331-0","volume":"93","author":"D Endres","year":"2022","unstructured":"Endres D, Domschke K, Schiele MA. Neurobiology of obsessive-compulsive disorder. Nervenarzt. 2022;93:670\u20137.","journal-title":"Nervenarzt"},{"key":"2368_CR12","unstructured":"Diagnostic and statistical manual of mental disorders: DSM-5. Washington, DC: American Psychiatric Publishing; 2013."},{"key":"2368_CR13","unstructured":"World Health Organization. International statistical classification of diseases and related health problems (11th ed.); 2019\/2021 https:\/\/icd.who.int\/browse11."},{"key":"2368_CR14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/104454602760386950","volume":"12","author":"P Gamazo-Garr\u00e1n","year":"2002","unstructured":"Gamazo-Garr\u00e1n P, Soutullo CA, Ortu\u00f1o F. Obsessive-compulsive disorder secondary to brain dysgerminoma in an adolescent boy: a positron emission tomography case report. J Child Adolesc Psychopharmacol. 2002;12:259\u201363.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"2368_CR15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1520-6394(1999)10:3<129::AID-DA7>3.0.CO;2-B","volume":"10","author":"F Hugo","year":"1999","unstructured":"Hugo F, van Heerden B, Zungu-Dirwayi N, Stein DJ. Functional brain imaging in obsessive-compulsive disorder secondary to neurological lesions. Depress Anxiety 1999;10:129\u201336.","journal-title":"Depress Anxiety"},{"key":"2368_CR16","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01700-4","volume":"12","author":"D Endres","year":"2022","unstructured":"Endres D, Pollak TA, Bechter K, Denzel D, Pitsch K, Nickel K, et al. Immunological causes of obsessive-compulsive disorder: is it time for the concept of an \u201cautoimmune OCD\u201d subtype? Transl Psychiatry. 2022;12:5.","journal-title":"Transl Psychiatry"},{"key":"2368_CR17","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1001\/jama.1994.03520220082035","volume":"272","author":"SE Swedo","year":"1994","unstructured":"Swedo SE. Sydenham\u2019s chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA. 1994;272:1788\u201391.","journal-title":"JAMA"},{"key":"2368_CR18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1176\/ajp.154.11.1630-b","volume":"154","author":"SE Swedo","year":"1997","unstructured":"Swedo SE, Leonard HL, Mittleman BB, Allen AJ, Rapoport JL, Dow SP, et al. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry. 1997;154:110\u20132.","journal-title":"Am J Psychiatry"},{"key":"2368_CR19","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s10096-014-2185-9","volume":"33","author":"S Esposito","year":"2014","unstructured":"Esposito S, Bianchini S, Baggi E, Fattizzo M, Rigante D. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: an overview. Eur J Clin Microbiol Infect Dis. 2014;33:2105\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2368_CR20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000522136","volume":"91","author":"D Endres","year":"2022","unstructured":"Endres D, Mertens L, Berger B, Reisert M, Runge K, Nickel K, et al. Autoimmune Obsessive-Compulsive Disorder with Novel Anti-Basal Ganglia Antibodies. Psychother Psychosom. 2022;91:214\u20136.","journal-title":"Psychother Psychosom"},{"key":"2368_CR21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fpsyt.2019.00226","volume":"10","author":"EM L\u00fcngen","year":"2019","unstructured":"L\u00fcngen EM, Maier V, Venhoff N, Salzer U, Dersch R, Berger B, et al. Systemic lupus erythematosus with isolated psychiatric symptoms and antinuclear antibody detection in the cerebrospinal fluid. Front Psychiatry. 2019;10:391.","journal-title":"Front Psychiatry"},{"key":"2368_CR22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00127-018-1622-y","volume":"54","author":"L-Y Wang","year":"2019","unstructured":"Wang L-Y, Chen S-F, Chiang J-H, Hsu C-Y, Shen Y-C. Systemic autoimmune diseases are associated with an increased risk of obsessive-compulsive disorder: a nationwide population-based cohort study. Soc Psychiatry Psychiatr Epidemiol. 2019;54:507\u201316.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2368_CR23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/diagnostics10090691","volume":"10","author":"D Endres","year":"2020","unstructured":"Endres D, Matysik M, Feige B, Venhoff N, Schweizer T, Michel M, et al. Diagnosing organic causes of schizophrenia spectrum disorders: findings from a one-year cohort of the Freiburg diagnostic protocol in psychosis (FDPP). Diagnostics. 2020;10:691.","journal-title":"Diagnostics"},{"key":"2368_CR24","unstructured":"International statistical classification of diseases and related health problems (Geneva, 2004)."},{"key":"2368_CR25","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-00967-3","volume":"10","author":"D Endres","year":"2020","unstructured":"Endres D, Meixensberger S, Dersch R, Feige B, Stich O, Venhoff N, et al. Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis. Transl Psychiatry. 2020;10:279.","journal-title":"Transl Psychiatry"},{"key":"2368_CR26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biopsych.2022.02.010","volume":"92","author":"D Endres","year":"2022","unstructured":"Endres D, Zedtwitz K, von, Matteit I, B\u00fcnger I, Foverskov-Rasmussen H, Runge K, et al. Spectrum of novel anti-central nervous system autoantibodies in the cerebrospinal fluid of 119 patients with schizophreniform and affective disorders. Biol Psychiatry. 2022;92:261\u201374.","journal-title":"Biol Psychiatry"},{"key":"2368_CR27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fimmu.2019.00514","volume":"10","author":"N Venhoff","year":"2019","unstructured":"Venhoff N, Thiel J, Rizzi M, Venhoff A, Rauer S, Endres D, et al. The MRZ-reaction and specific autoantibody detection for differentiation of ANA-positive multiple sclerosis from rheumatic diseases with cerebral involvement. Front Immunol 2019;10:514.","journal-title":"Front Immunol"},{"key":"2368_CR28","doi-asserted-by":"publisher","unstructured":"Pankratz B, Zedtwitz K von, Runge K, Denzel D, Nickel K, Schlump A, et al. Cerebrospinal fluid findings in adult patients with obsessive-compulsive disorder: a retrospective analysis of 54 samples. World J Biol Psychiatry. 2022;1\u201326 https:\/\/doi.org\/10.1080\/15622975.2022.2104457.","DOI":"10.1080\/15622975.2022.2104457"},{"key":"2368_CR29","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.cell.2020.09.049","volume":"183","author":"J Kreye","year":"2020","unstructured":"Kreye J, Reincke SM, Kornau H-C, S\u00e1nchez-Sendin E, Corman VM, Liu H, et al. A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model. Cell. 2020;183:1058\u20131069.e19.","journal-title":"Cell"},{"key":"2368_CR30","first-page":"e20210012","volume":"218","author":"J Kreye","year":"2021","unstructured":"Kreye J, Wright SK, van Casteren A, St\u00f6ffler L, Machule M-L, Reincke SM, et al. Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizures. J Exp Med. 2021;218:e20210012.","journal-title":"J Exp Med"},{"key":"2368_CR31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.yebeh.2017.06.039","volume":"75","author":"D Endres","year":"2017","unstructured":"Endres D, Maier S, Feige B, Mokhtar NB, Nickel K, Goll P, et al. Increased rates of intermittent rhythmic delta and theta activity in the electroencephalographies of adult patients with attention-deficit hyperactivity disorder. Epilepsy Behav. 2017;75:60\u201365.","journal-title":"Epilepsy Behav"},{"key":"2368_CR32","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1080\/15622975.2022.2042599","volume":"23","author":"D Endres","year":"2022","unstructured":"Endres D, Pankratz B, Thiem S, Runge K, Schlump A, Feige B, et al. Novel anti-cytoplasmic antibodies in cerebrospinal fluid and serum of patients with chronic severe mental disorders. World J Biol Psychiatry. 2022;23:794\u2013801.","journal-title":"World J Biol Psychiatry"},{"key":"2368_CR33","doi-asserted-by":"publisher","unstructured":"Endres D, Schiele MA, Frye BC, Schlump A, Feige B, Nickel K, et al. Obsessive-compulsive disorder with inflammatory cerebrospinal fluid changes and intrathecal antinuclear antibody staining. Biol Psychiatry. 2022. https:\/\/doi.org\/10.1016\/j.biopsych.2022.06.037.","DOI":"10.1016\/j.biopsych.2022.06.037"},{"key":"2368_CR34","doi-asserted-by":"publisher","unstructured":"Endres D, Pankratz B, Robinson T, Pitsch K, G\u00f6bel T, Runge K, et al. Autoimmune obsessive-compulsive disorder with novel anti-CNS autoantibodies in cerebrospinal fluid. Mol Psychiatry. 2022. https:\/\/doi.org\/10.1038\/s41380-022-01688-3.","DOI":"10.1038\/s41380-022-01688-3"},{"key":"2368_CR35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391\u2013404.","journal-title":"Lancet Neurol"},{"key":"2368_CR36","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00702-022-02544-y","volume":"129","author":"T G\u00f6bel","year":"2022","unstructured":"G\u00f6bel T, Berninger L, Schlump A, Feige B, Runge K, Nickel K, et al. Obsessive-compulsive symptoms in ACTG1-associated Baraitser-Winter cerebrofrontofacial syndrome. J Neural Transm. 2022;129:1387\u201391.","journal-title":"J Neural Transm"},{"key":"2368_CR37","doi-asserted-by":"publisher","unstructured":"Matteit I, Schlump A, Reisert M, Zedtwitz KV, Runge K, Nickel K, et al. Obsessive-compulsive symptoms in two patients with chromosomal disorders involving the X chromosome. World J Biol Psychiatry 2022;1\u20136 https:\/\/doi.org\/10.1080\/15622975.2022.2147997.","DOI":"10.1080\/15622975.2022.2147997"},{"key":"2368_CR38","doi-asserted-by":"crossref","first-page":"104518","DOI":"10.1016\/j.psyneuen.2019.104518","volume":"112","author":"GJLJ Snijders","year":"2020","unstructured":"Snijders GJLJ, Witte LD, de, van den Berk D, van der Laan C, Regeer E, Begemann MJH, et al. No association between anti-thyroidperoxidase antibodies and bipolar disorder: a study in the Dutch Bipolar Cohort and a meta-analysis. Psychoneuroendocrinology. 2020;112:104518.","journal-title":"Psychoneuroendocrinology"},{"key":"2368_CR39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.genhosppsych.2013.10.002","volume":"36","author":"M Giynas Ayhan","year":"2014","unstructured":"Giynas Ayhan M, Uguz F, Askin R, Gonen MS. The prevalence of depression and anxiety disorders in patients with euthyroid Hashimoto\u2019s thyroiditis: a comparative study. Gen Hosp Psychiatry. 2014;36:95\u201398.","journal-title":"Gen Hosp Psychiatry"},{"key":"2368_CR40","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000026545","volume":"38","author":"GP Placidi","year":"1998","unstructured":"Placidi GP, Boldrini M, Patronelli A, Fiore E, Chiovato L, Perugi G, et al. Prevalence of psychiatric disorders in thyroid diseased patients. Neuropsychobiology. 1998;38:222\u20135.","journal-title":"Neuropsychobiology"},{"key":"2368_CR41","doi-asserted-by":"crossref","first-page":"19l02463","DOI":"10.4088\/PCC.19l02463","volume":"22","author":"A \u00c7ayk\u00f6yl\u00fc","year":"2020","unstructured":"\u00c7ayk\u00f6yl\u00fc A, U\u011furlu GK, Yenilmez DO, \u00c7ayk\u00f6yl\u00fc HH, U\u011furlu M. Subthreshold obsessive-compulsive symptoms in 3 patients with papillary thyroid carcinoma. Prim Care Companion CNS Disord. 2020;22:19l02463.","journal-title":"Prim Care Companion CNS Disord"},{"key":"2368_CR42","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/mp.2017.215","volume":"23","author":"D Mataix-Cols","year":"2018","unstructured":"Mataix-Cols D, Frans E, P\u00e9rez-Vigil A, Kuja-Halkola R, Gromark C, Isomura K, et al. A total-population multigenerational family clustering study of autoimmune diseases in obsessive-compulsive disorder and Tourette\u2019s\/chronic tic disorders. Mol Psychiatry. 2018;23:1652\u20138.","journal-title":"Mol Psychiatry"},{"key":"2368_CR43","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/art.41214","volume":"72","author":"GE Dinse","year":"2020","unstructured":"Dinse GE, Parks CG, Weinberg CR, Co CA, Wilkerson J, Zeldin DC, et al. Increasing prevalence of antinuclear antibodies in the United States. Arthritis Rheumatol. 2020;72:1026\u201335.","journal-title":"Arthritis Rheumatol"},{"key":"2368_CR44","first-page":"11801","volume":"24","author":"J Freire de Carvalho","year":"2020","unstructured":"Freire de Carvalho J, Machado Ribeiro F. Sj\u00f6gren syndrome associated with obsessive-compulsive disorder. Eur Rev Med Pharmacol Sci. 2020;24:11801\u20133.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2368_CR45","doi-asserted-by":"publisher","unstructured":"Pr\u00fcss H. Autoantibodies in neurological disease. Nat Rev Immunol. 2021. https:\/\/doi.org\/10.1038\/s41577-021-00543-w.","DOI":"10.1038\/s41577-021-00543-w"},{"key":"2368_CR46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.sleep.2020.03.019","volume":"72","author":"Q Ding","year":"2020","unstructured":"Ding Q, Li J, Xiao F, Zhang C, Dong X, Han F. Anti-streptococcal antibodies in Chinese patients with type-1 narcolepsy. Sleep Med. 2020;72:37\u201340.","journal-title":"Sleep Med"},{"key":"2368_CR47","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/jamapsychiatry.2017.0995","volume":"74","author":"S Orlovska","year":"2017","unstructured":"Orlovska S, Vestergaard CH, Bech BH, Nordentoft M, Vestergaard M, Benros ME. Association of streptococcal throat infection with mental disorders: testing key aspects of the PANDAS hypothesis in a nationwide study. JAMA Psychiatry. 2017;74:740\u20136.","journal-title":"JAMA Psychiatry"},{"key":"2368_CR48","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/ajp.155.2.264","volume":"155","author":"SE Swedo","year":"1998","unstructured":"Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155:264\u201371.","journal-title":"Am J Psychiatry"},{"key":"2368_CR49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12011-012-9371-3","volume":"148","author":"H Shohag","year":"2012","unstructured":"Shohag H, Ullah A, Qusar S, Rahman M, Hasnat A. Alterations of serum zinc, copper, manganese, iron, calcium, and magnesium concentrations and the complexity of interelement relations in patients with obsessive-compulsive disorder. Biol Trace Elem Res. 2012;148:275\u201380.","journal-title":"Biol Trace Elem Res"},{"key":"2368_CR50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1507\/endocrj.K06-152","volume":"54","author":"Y Chiba","year":"2007","unstructured":"Chiba Y, Satoh K, Ueda S, Kanazawa N, Tamura Y, Horiuchi T. Marked improvement of psychiatric symptoms after parathyroidectomy in elderly primary hyperparathyroidism. Endocr J. 2007;54:379\u201383.","journal-title":"Endocr J"},{"key":"2368_CR51","doi-asserted-by":"crossref","first-page":"e0157232","DOI":"10.1371\/journal.pone.0157232","volume":"11","author":"H Umehara","year":"2016","unstructured":"Umehara H, Numata S, Tajima A, Nishi A, Nakataki M, Imoto I, et al. Calcium signaling pathway is associated with the long-term clinical response to selective serotonin reuptake inhibitors (SSRI) and SSRI with antipsychotics in patients with obsessive-compulsive disorder. PLoS ONE. 2016;11:e0157232.","journal-title":"PLoS ONE"},{"key":"2368_CR52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/eurheartj\/ehz785","volume":"41","author":"U Laufs","year":"2020","unstructured":"Laufs U, Parhofer KG, Ginsberg HN, Hegele RA. Clinical review on triglycerides. Eur Heart J. 2020;41:99\u2013109c.","journal-title":"Eur Heart J"},{"key":"2368_CR53","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1192\/bjo.2021.1039","volume":"7","author":"TP Nguyen","year":"2021","unstructured":"Nguyen TP, Cribb L, Ng CH, Byrne GJ, Castle D, Brakoulias V, et al. Dietary quality and nutrient intake in adults with obsessive-compulsive disorder. BJPsych Open. 2021;7:e218. https:\/\/doi.org\/10.1192\/bjo.2021.1039.","journal-title":"BJPsych Open"},{"key":"2368_CR54","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.psychres.2017.04.032","volume":"254","author":"E Esnafo\u011flu","year":"2017","unstructured":"Esnafo\u011flu E, Yaman E. Vitamin B12, folic acid, homocysteine and vitamin D levels in children and adolescents with obsessive compulsive disorder. Psychiatry Res. 2017;254:232\u20137.","journal-title":"Psychiatry Res"},{"key":"2368_CR55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5152\/npa.2015.8763","volume":"53","author":"G \u00c7elik","year":"2016","unstructured":"\u00c7elik G, TA\u015e D, Tahiro\u011flu A, AVCI A, Y\u00dcKSEL B, \u00c7AM P. Vitamin D deficiency in obsessive-compulsive disorder patients with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: a case control study. Noro Psikiyatr Ars. 2016;53:33\u201337.","journal-title":"Noro Psikiyatr Ars"},{"key":"2368_CR56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/08039488.2017.1406985","volume":"72","author":"KU Yazici","year":"2018","unstructured":"Yazici KU, Percinel Yazici I, Ustundag B. Vitamin D levels in children and adolescents with obsessive compulsive disorder. Nord J Psychiatry. 2018;72:173\u20138.","journal-title":"Nord J Psychiatry"},{"key":"2368_CR57","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000514075","volume":"80","author":"E Balandeh","year":"2021","unstructured":"Balandeh E, Karimian M, Behjati M, Mohammadi AH. Serum vitamins and homocysteine levels in obsessive-compulsive disorder: a systematic review and meta-analysis. Neuropsychobiology. 2021;80:502\u201315.","journal-title":"Neuropsychobiology"},{"key":"2368_CR58","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2174\/1381612824666180417124919","volume":"24","author":"F Di Michele","year":"2018","unstructured":"Di Michele F, Siracusano A, Talamo A, Niolu C. N-acetyl cysteine and vitamin D supplementation in treatment resistant obsessive-compulsive disorder patients: a general review. Curr Pharm Des. 2018;24:1832\u20138.","journal-title":"Curr Pharm Des"},{"key":"2368_CR59","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1440-1819.2005.01425.x","volume":"59","author":"M Atmaca","year":"2005","unstructured":"Atmaca M, Tezcan E, Kuloglu M, Kirtas O, Ustundag B. Serum folate and homocysteine levels in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci. 2005;59:616\u201320.","journal-title":"Psychiatry Clin Neurosci"},{"key":"2368_CR60","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00429-018-1752-8","volume":"224","author":"KCD Oliveira","year":"2019","unstructured":"Oliveira KCD, Grinberg LT, Hoexter MQ, Brentani H, Suemoto CK, Nery FG, et al. Layer-specific reduced neuronal density in the orbitofrontal cortex of older adults with obsessive-compulsive disorder. Brain Struct Funct. 2019;224:191\u2013203.","journal-title":"Brain Struct Funct"},{"key":"2368_CR61","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/pcn.12195","volume":"68","author":"T Nakao","year":"2014","unstructured":"Nakao T, Okada K, Kanba S. Neurobiological model of obsessive-compulsive disorder: evidence from recent neuropsychological and neuroimaging findings. Psychiatry Clin Neurosci. 2014;68:587\u2013605.","journal-title":"Psychiatry Clin Neurosci"},{"key":"2368_CR62","doi-asserted-by":"publisher","unstructured":"Caykoylu A, Kabadayi Sahin E, Ugurlu M. Could the thyroid gland dominate the brain in obsessive-compulsive disorder? Neuroendocrinology. 2022. https:\/\/doi.org\/10.1159\/000524627.","DOI":"10.1159\/000524627"},{"key":"2368_CR63","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41398-021-01276-z","volume":"11","author":"F Piras","year":"2021","unstructured":"Piras F, Piras F, Abe Y, Agarwal SM, Anticevic A, Ameis S, et al. White matter microstructure and its relation to clinical features of obsessive-compulsive disorder: findings from the ENIGMA OCD Working Group. Transl Psychiatry. 2021;11:173","journal-title":"Transl Psychiatry"},{"key":"2368_CR64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.yebeh.2011.06.016","volume":"22","author":"L Tebartz van Elst","year":"2011","unstructured":"Tebartz van Elst L, Krishnamoorthy ES, Schulze-Bonhage A, Altenm\u00fcller D-M, Richter H, Ebert D, et al. Local area network inhibition: a model of a potentially important paraepileptic pathomechanism in neuropsychiatric disorders. Epilepsy Behav. 2011;22:231\u20139.","journal-title":"Epilepsy Behav"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02368-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02368-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02368-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T15:09:16Z","timestamp":1678201756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02368-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2368"],"URL":"https:\/\/doi.org\/10.1038\/s41398-023-02368-8","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]},"assertion":[{"value":"5 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HU: Speaker fees from Bayer AG, Bracco, Eisai, Stryker, and UCB Pharma. KD: Steering Committee Neurosciences, Janssen. Speaker fees from Janssen. LTvE: Advisory boards, lectures, or travel grants within the last three years: Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen and Cyberonics. All other authors have no potential conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}